Estimation of prothrombin time, activated partial thromboplastin time and thrombocytes among Sudanese patients with diabetes

Ibrahim Abdallah Mohammed Omer

doi:10.30574/gscbps.2020.10.1.0250

Authors

Ibrahim Abdallah Mohammed Omer Omdurman Islamic University, Faculty of Medical Laboratory Sciences, Department of Hematology, Khartoum, Sudan.

DOI:

https://doi.org/10.30574/gscbps.2020.10.1.0250

Keywords:

PT, INR PTT, Platelet, Diabetes

Abstract

Diabetes mellitus is a common disease in Sudan, and it is a major cause of morbidity, several studies indicate that diabetes is a likely under reported as cause of death. This study aimed to evaluate of Prothrombin Time, Activated Partial Thromboplastin Time and Thrombocytes among Sudanese Patients with diabetes. This study includes 57 patients have diabetic and 20 persons as control. The blood coagulation markers, PT, INR and aPTT were measured by coagulation analyzer and thrombocytes count by hematological analyzer (Sysmex). Data analysis was performed using statistical package for social science (SPSS) software. Evaluation of patient’s data was performed using the t-test and Pearson correlation test. Results with p value < 0.05 were considered as statistically significant. This study concluded that patients with diabetes mellitus are more prone to develop hypercoagulation state, and it may be close to that diabetic patients are accelerated to develop coagulation impairment. Routine examinations of PT, INR, APTT and Thrombocyte count are important to assess coagulation impairment among diabetic patients in order to prevent any thromboembolic complication.

Metrics

Metrics Loading ...

References

Rashid, Sarra Izzeldin, Nuha Mohamed A. Agabna and Asaad MA Babker. "Evaluation of Insulin Prescriptions in Type 2 Diabetic Patients in Jabir Aboeliz Health Center. Scholars Academic Journal of Pharmacy, 6(2), 67-70.

Zimmet P, Alberti KG and Shaw J. (2001). Global and societal implications of the diabetes epidemic. Nature, 414(6865), 782-7.

Soares, Anna L, Sousa, Marinez dO, Fernandes, Ana PSM, Carvalho and Maria dG. (2010). Hemostatic changes in patients with type 2 diabetes mellitus. Revista Brasileira de Hematologia e Hemoterapia, 32(6), 482-488.

Ceriello A. (1993). Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36, 1119–1125.

Bashir BA and Ali MS. (2018). Hemostatic state augmented with platelet indices among Sudanese diabetic septic foot. BMC hematology, 18, 11.

Ali NM, Gameel FE, Elsayid M and Babker AM. (2016). Alterations in D-Dimer, Prothrombin Time and Activated Partial Thromboplastin Time as Thrombogenesis Activity Markers in Patients with Acute Myocardial Infarction. Open Journal of Blood Diseases, 11, 6(01), 1.

Agabeldour AA, Khalafallah TO and AbdAllah AM. (2015). Hematological changes among Sudanese petroleum workers with a broad range of benzene exposure: Sch. J. App. Med. Sci., 3(8D), 3054-6.

Ankalayya B, HS Sodhi, Sudhir Modala and Manisha Baghel. (2016). A Comparative study of coagulation time in type 2 diabetes mellitus and healthy individuals. International Journal of Contemporary Medical Research, 3(11), 3170-3171.

Soltani MM, Dayer MR, Zahed AS, Bahar HA and Nasirbagheban Z. (2012). The Buffering role of HDL in balancing the effects of hypercoagulable state in type 2 Diabetes. J Appl Sci., 12(8), 745-52.

Mard-Soltani M., MR Dayer, M Taheri-Shoshi, G Ataie, AA Moazedi and AH Shamshirgar-Zadeh. (2011). Cholesterol and lipoproteins have an important role in homeostasis of coagulation factors in type 2 diabetes mellitus. Clin. Biochem., 44, S55-S59.

Bae SH, Lee J, Roh KH and Kim J. (2003). Platelet activation in patient with diabetic retinopathy. Korean J Opthalmol, 17, 140-4.

Hamid RDMN. (2017). Estimation of Prothrombin Time, Activated Partial Thromboplastin Time and platelets count in Diabetes Type II patients in Khartoum State (Doctoral dissertation, Sudan University of Science & Technology).

Matcas HA. (2009) Study on the anomalies of hemostasis on a group of dislipoproteinemia patients [master thesis]. [Craiova]: University of Medicine and Pharmacy Craiova, 139.

Karim F, Akter QS, Jahan S, Khanom A, Haque S, Yeasmin T, Siddika T and Sinha S. (2015). Coagulation Impairment in type 2 diabetes mellitus. Journal of Bangladesh Society of Physiologist, 21, 10(1), 26-9.

Hekimsoy Z, Payzinb B, Ornek T and Kandogan G. (2004). Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications, 18(3), 173–176.

Thomas AK, Udaya KM, Suraksha BR, Thej MJ, Madheri R, Harendra KML and Venkataswamy L. (2012). Mean platelet volume in type 2 diabetes mellitus. J lab physicians, 4(1), 5–9.

Akinsegun A, Akinola Olusola D, Sarah JO, Olajumoke O, Adewumi A, Majeed O, Anthonia O, Ebele U, Olaitan O, Olanrewaju A and Kingsley A. (2014). Mean platelet volume and platelet counts in type 2 diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria. Pan Afr Med J. 12, 18, 42.

Chen X, Fang L, Lin H, Shen P, Zhang T, Li H, Li X, Yu M, Xu C, Zhang J, Lu F, DU X, Hu R and Zhong J. The Relationship between Type 2 Diabetes and Platelet Indicators. Iran J Public Health. 2017 Sep, 46(9), 1211-1216.

Babker AM and Gameel FE. (2015). Molecular Characterization of Prothrombin G20210A gene Mutations In pregnant Sudanese women with spontaneous recurrent abortions. Rawal Medical Journal, 40(2):207-9.

Mohamed AO, Hamza KM and Babker AM. (2016). Physiological changes in some hematological and coagulation profile among Sudanese healthy pregnant women. Int J Med Sci Public Health. 1, 5(3), 525-8.

Mustafa, ME, Mansoor MM, Mohammed A and Babker AA. (2015). Evaluation of Platelets Count and Coagulation Parameters among Patients with Liver Disease. World Journal of Pharmaceutical Research, 4, 360-368.